Skip to main content

Table 1 Participants’ baseline characteristics (N = 100)

From: Effect and safety of pemafibrate for patients with type 2 diabetes mellitus and hypertriglyceridemia: a retrospective analysis of clinical data

 

N (%) or mean (SD)

Sex (male)

72.0

(72.0)

Age (y)

59.2

(9.9)

BMI (kg/m2)

26.3

(4.1)

Weight (kg)

73.6

(14.4)

HbA1c (%)

6.61

(0.77)

Triglycerides (mg/dL)

278.9

(136.4)

HDL-C (mg/dL)

49.2

(9.9)

LDL-C (mg/dL)

93.2

(19.9)

Serum creatinine (mg/dL)

0.78

(0.19)

eGFR (mL/min/1.73 m2)

77.5

(16.8)

  1. Data are n (%) or mean (SD; standard deviation) values
  2. BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; eGFR, estimated glomerular filtration rate
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us